8-K ·Filed May 12, 2026

VREOF

Vireo Growth Inc.
BEARISH
Impact 7/10
Horizonweeks Processed4mo ago SEC0001104659-26-059005
8-K Item 2.02: Earnings release
Actionable Insight ▼ Bearish

The headline revenue growth is entirely M&A-driven and masks weak organic trends (pro-forma revenue +5%). The massive EPS miss and widening net loss, combined with a 3x increase in share count, signal significant shareholder dilution. The S-3 shelf filing 19 days before earnings suggests capital needs. Monitor integration of Eaze, Hawthorne, and FLUENT for margin and cash flow impact; the $133.8M uncertain tax liability is a material overhang.

DirectionBearish
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
VREOF ▼ -17.20% at T+60d
SHORT call ✓ call won +17.20% · α vs SPY +21.59% · entry $12.09 → $10.01
Entry anchored
May 12, 2026
via day open
T+1d
+2.98%
call -2.98% · α -2.42%
$12.45
settled 5mo ago
T+5d
-3.23%
call +3.23% · α +2.62%
$11.70
settled 5mo ago
T+20d
+6.70%
call -6.70% · α -8.43%
$12.90
settled 4mo ago
T+60d
-17.20%
call +17.20% · α +21.59%
$10.01
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Vireo Growth Inc. reported Q1 2026 GAAP revenue of $106.2M, up 333.5% YoY, but driven entirely by M&A (Schwazze, Eaze, Hawthorne closed post-quarter). On a pro-forma basis, revenue grew only 5.0% to $210.2M. The company posted a GAAP net loss of $20.3M (vs $6.5M loss a year ago) and EPS of -$0.02, missing the consensus estimate of $0.01. The massive share count increase (from 367M to 1.08B weighted average shares) and heavy transaction expenses ($8.7M) and contingent consideration charges ($5.5M) overshadowed the revenue growth.

Key Financial Metrics

EPS
$-0.02
est $0.01 · -300.0%
Revenue
$106.2M
est $108.6M · -2.2% · +333.5% YoY
Rating
strong miss
Free Cash Flow
$1.1M
Gross Margin
55.8%

Key Facts

  • Q1 2026 GAAP revenue $106.2M vs $24.5M YoY (+333.5%), but pro-forma revenue only $210.2M vs $200.1M (+5.0%)
  • GAAP net loss of $20.3M widened from $6.5M loss in Q1 2025
  • EPS of -$0.02 missed consensus estimate of $0.01 (a 300% miss)
  • Adjusted EBITDA (non-GAAP) was $32.7M vs $6.6M YoY, but pro-forma Adjusted EBITDA was $42.2M vs $32.5M (+29.8%)
  • Cash and restricted cash at quarter end: $137.8M, up from $86.2M a year ago
  • Weighted average shares outstanding ballooned to 1.08B from 367M YoY due to stock-based M&A consideration
  • Uncertain tax liability grew to $133.8M from $120.0M at year-end 2025
  • S-3 shelf filed 19 days prior for resale of 3.1M shares by selling securityholders
  • Post-quarter closed Eaze and Hawthorne acquisitions, announced FLUENT acquisition and Glass House JV

Financial Impact

GAAP revenue $106.2M (+333.5% YoY), net loss $20.3M, EPS -$0.02 vs consensus $0.01

revenueepsnet incomedilutiondebt

Risk Factors

  • Massive share dilution from stock-based M&A (shares outstanding increased ~3x YoY)
  • Widening GAAP net loss ($20.3M vs $6.5M) despite revenue growth
  • Uncertain tax liability of $133.8M could crystallize into cash outflows
  • Integration risk from multiple concurrent acquisitions (Schwazze, Eaze, Hawthorne, FLUENT)
  • S-3 shelf filing suggests potential further dilution or capital raise

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
0% bullish (9 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001104659-26-059005
Document: vreof-20260512x8k.htm0001104659-26-059005
Document: 0001104659-26-059005-index-headers.html0001104659-26-059005
Document: 0001104659-26-059005-index.html0001104659-26-059005
Document: 0001104659-26-059005.txt0001104659-26-059005
8-K Data (Synthetic)0001104659-26-059005
13 reports for VREOF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VREOF — sortable, filterable
TypeNow
Aug 18, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$10.97 $12.11▲ +10.39%▲ +11.91%$9.61 (−12.40%)
Aug 11, 2026
7w ago
8-K
MIXED ★ 6/10
$10.64 $12.12▲ +13.91%▲ +14.97%$9.61 (−9.68%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$10.01 $10.84▲ +8.29%▲ +7.69%$9.61 (−4.00%)
Jul 30, 2026
9w ago
8-K
NEUTRAL ★ 5/10
$9.44 $10.60▲ +12.29%▲ +9.30%$9.61 (+1.80%)
Jul 27, 2026
9w ago
8-K
NEUTRAL ★ 5/10
$9.70 $10.89▲ +12.27%▲ +8.97%$9.61 (−0.93%)
Jun 18, 2026
15w ago
8-K
BULLISH ★ 6/10
$10.42 $9.80▼ −5.95%▼ −5.64%$9.61 (−7.77%)
Jun 11, 2026
16w ago
8-K
MIXED ★ 5/10
$12.46 $10.02▼ −19.58%▼ −20.84%$9.61 (−22.87%)
Jun 9, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$12.90 $9.82▼ −23.88%▼ −27.77%$9.61 (−25.50%)
May 29, 2026
18w ago
8-K
MIXED ★ 6/10
$13.05 $9.99▼ −23.47%▼ −22.17%$9.61 (−26.34%)
May 12, 2026
20w ago
8-K
BEARISH ★ 7/10
$12.09 $12.90▼ −6.70%▼ −8.43%$9.61 (+20.51%)
Showing 10 of 13

US Market Status

Market Closed — Opens Mon (37h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access